Please note that the details of this Challenge are no longer open. This challenge is awarded and is no longer accepting new submissions. You can:
Challenge Help Reduce the Placebo Effect in Clinical Drug Trials!
Help Reduce the Placebo Effect in Clinical Drug Trials!
STATUS: Awarded
Active Solvers: 500
Posted: Feb 10 2010
Challenge ID: 9188486
 
Share Challenge Share
Abstract
Markers predictive of placebo-responders in clinical drug trials, or rational for improved trial designs, are required in order to increase the efficacy of clinical drug trials and better understand the effects of human therapies.

This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker.
Overview
Placebo responses in as many as 60% of the placebo-receiving patients often mask the efficacy of drugs in clinical trials. Biomarkers predictive of placebo responders or new methods of trial design and trial procedure are desired. The biomarker, trial design, or procedure would allow individuals likely to show a placebo-response to be identified and excluded from trials during the patient selection process.
What is InnoCentive?
InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.

What is a Theoretical-Licensing Challenge?

An InnoCentive Theoretical Challenge builds upon an idea but is not yet a proof of concept. A solution to a Theoretical Challenge will solidify the Solver's concept with detailed descriptions, specifications and requirements necessary to bringing a good idea closer to becoming an actual product or service.

This Challenge is a Theoretical-Licensing Challenge, meaning that the Seeker is requesting non-exclusive rights to use the winning solution. By contrast, Theoretical-IP Transfer means that Solvers must relinquish all rights to the Intellectual Property (IP) for which they are awarded. For these forms of a Theoretical Challenge, Solvers that do not win retain the rights to their solution after the evaluation period is complete. The Seeker retains no rights to any IP not awarded.

Share This Challenge
InnoCentive Trust Partners